This page exists for two reasons: to answer common questions clearly, and to help search engines understand what the site is actually about.
The role is there to own the early AI decisions: where AI should be used, what should be ignored, what the operating model looks like, how governance is handled, and how the first useful workflow reaches production.
A normal consultant may leave after the strategy phase. A founder-led fractional model stays closer to the decisions and the delivery so the plan does not collapse the moment implementation begins.
Usually when the company needs senior AI judgment now, but does not yet need a permanent executive hire. It is a useful bridge between curiosity and a fully built-out AI function.
No. The positioning is broader than pharma, but still narrow by design: regulated and trust-sensitive European companies where governance, accountability, and workflow design matter.
No, but someone inside the company does need to own the business side and support decisions. The model works best when there is an executive sponsor and at least some ability to implement changes over time.
Usually identify the workflow that matters most, understand the real bottleneck, map the risks and dependencies, and decide whether the best next step is a roadmap sprint, an embedded engagement, or something else.